ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bristol-Myers Squibb's Opdivo in combination with low-dose Yervoy approved in Europe for first-line advanced RCC
January 15, 2019The CheckMate -214 study compared the efficacy of Opdivo plus low-dose Yervoy versus Pfizer's Sutent (sunitinib) in patients with previously untreated advanced RCC. The late-stage study was stopped early after the combination regimen demonstrated superior
Pharma Sources Insight January 2025
